About the Joint Action
The general obective of the iPAAC Joint Action (JA) is to develop innovative approaches to advances in cancer control. The innovation that will be covered within the JA consists of further development of cancer prevention, comprehensive approaches to the use of genomics in cancer control, cancer information and registries, improvements and challenges in cancer care, mapping of innovative cancer treatments and governance of integrated cancer control, including a new analysis of National Cancer Control Plans. The key focus of the Joint Action will be on implementation, as reflected in the key deliverable, i.e. the Roadmap on Implementation and Sustainability of Cancer Control Actions, which will support member states in the implementation of iPAAC and CANCON recommendations.
million EUR co-funding by EC
44 partners (Competent Authorities and Affiliated Entities)
08 Apr 2022
iPAAC JA has ended – thank you all
As the iPAAC JA has come to the end, we would like to thank all the partners of the Consortium, our very special thanks go to the Work Package Leaders, who have done a lot of the groundwork in their respective specialised areas. We could not have achieved this much without the strong commitment, dedicated work, and efforts of all partners in the consortium in reaching our joint objectives and completing our deliverables.